Alternative Calculations of Individual Patient Time in Therapeutic Range While Taking Warfarin: Results From the ROCKET AF Trial

BACKGROUND: In the ROCKET AF (Rivaroxaban–Once‐daily, oral, direct Factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) trial, marked regional differences in control of warfarin anticoagulation, measured as the average individual...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Singer, Daniel E., Hellkamp, Anne S., Yuan, Zhong, Lokhnygina, Yuliya, Patel, Manesh R., Piccini, Jonathan P., Hankey, Graeme J., Breithardt, Günter, Halperin, Jonathan L., Becker, Richard C., Hacke, Werner, Nessel, Christopher C., Mahaffey, Kenneth W., Fox, Keith A. A., Califf, Robert M.
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4392426/
https://ncbi.nlm.nih.gov/pubmed/25736441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.114.001349
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados